Daihan PharmaceuticalLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 64.72% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
24.6%	Yoon-Woo Lee	1,446,743	₩37.6b	0.41%	no data
16.2%	State Street Global Advisors, Inc.	951,658	₩24.7b	0%	no data
9.19%	FMR LLC	540,201	₩14.0b	0%	no data
6.48%	Seungyoung Lee	381,041	₩9.9b	0.32%	no data
5.07%	Mirae Asset Global Investments Co., Ltd.	298,184	₩7.8b	0%	no data
1.8%	Dimensional Fund Advisors LP	105,653	₩2.7b	-5.23%	no data
0.39%	Chang-Min Oh	23,040	₩599.0m	0%	no data
0.34%	Young-Ki Cho	20,000	₩520.0m	0%	no data
0.23%	Midas Asset Management	13,350	₩347.1m	0%	0.03%
0.12%	Acadian Asset Management LLC	6,778	₩176.2m	0%	no data
0.083%	Mackenzie Financial Corporation	4,878	₩126.8m	0%	no data
0.071%	Niche Asset Management Limited	4,200	₩109.2m	0%	0.01%
0.071%	AXA Investment Managers S.A.	4,150	₩107.9m	0%	no data
0.04%	Fidelity International Ltd	2,351	₩61.1m	0%	no data
0.03%	Lingohr Asset Management GmbH	1,775	₩46.2m	0%	no data
0.026%	KB Asset Management Co., Ltd.	1,500	₩39.0m	0%	no data